Open Access731 RISK OF ESOPHAGEAL AND GASTRIC ADENOCARCINOMA IN MEN RECEIVING ANDROGEN DEPRIVATION THERAPY FOR PROSTATE CANCER
Author(s) -
Richard Shore,
Jingru Yu,
Weimin Ye,
Jesper Lagergren,
Martin Rutegård,
Olof Akre,
Pär Stattin,
Mats Lindblad
Publication year - 2021
Publication title -
diseases of the esophagus
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.115
H-Index - 63
eISSN - 1442-2050
pISSN - 1120-8694
DOI - 10.1093/dote/doab052.731
Subject(s) - medicine , adenocarcinoma , hazard ratio , androgen deprivation therapy , gastroenterology , cancer , prostate cancer , population , proportional hazards model , oncology , cohort , confidence interval , environmental health
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom